NEWS

Philips announces WE-TRUST multicenter clinical trial to assess impact o...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major clinical trial to assess the impact of a ‘Direct to Angio Suite’ workflow on stroke patient outcomes.

Endovascular Treatment of Brain Aneurysms

LINNC ASIA 2019, the second day

Linnc Asia 2019, Day 1: read the full report now!

First use of LVIS Evo stent in England

Second stroke patient treated with Cyclical Aspiration

Third stroke patient treated with Cyclical Aspiration

Perflow Medical Receives CE Mark Approval of Novel Cascade™ Agile

Promising clinical data for Cascade Net published in the Journal of NeuroInterventional Surgery

Life, Stroke & Destiny. Not everyone so Lucky !

First stroke patient treated with Cyclical Aspiration